- Home
- REAL vs VALN Comparison
REAL vs VALN Comparison
Compare REAL & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- VALN
- Stock Information
- Founded
- REAL 2011
- VALN 2012
- Country
- REAL United States
- VALN France
- Employees
- REAL N/A
- VALN N/A
- Industry
- REAL Other Specialty Stores
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REAL Consumer Discretionary
- VALN Health Care
- Exchange
- REAL Nasdaq
- VALN Nasdaq
- Market Cap
- REAL 718.6M
- VALN 595.2M
- IPO Year
- REAL 2019
- VALN 2021
- Fundamental
- Price
- REAL $5.50
- VALN $6.79
- Analyst Decision
- REAL Buy
- VALN Strong Buy
- Analyst Count
- REAL 6
- VALN 2
- Target Price
- REAL $8.00
- VALN $17.00
- AVG Volume (30 Days)
- REAL 3.8M
- VALN 49.8K
- Earning Date
- REAL 05-06-2025
- VALN 05-06-2025
- Dividend Yield
- REAL N/A
- VALN N/A
- EPS Growth
- REAL N/A
- VALN N/A
- EPS
- REAL N/A
- VALN N/A
- Revenue
- REAL $600,484,000.00
- VALN $176,817,979.00
- Revenue This Year
- REAL $11.62
- VALN $22.53
- Revenue Next Year
- REAL $10.06
- VALN $7.29
- P/E Ratio
- REAL N/A
- VALN N/A
- Revenue Growth
- REAL 9.32
- VALN N/A
- 52 Week Low
- REAL $2.24
- VALN $3.62
- 52 Week High
- REAL $11.38
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- REAL 35.11
- VALN 50.17
- Support Level
- REAL $4.90
- VALN $6.71
- Resistance Level
- REAL $5.96
- VALN $7.29
- Average True Range (ATR)
- REAL 0.50
- VALN 0.36
- MACD
- REAL -0.04
- VALN -0.13
- Stochastic Oscillator
- REAL 26.84
- VALN 6.00
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.